Abhijit Pethe

1.1k total citations
37 papers, 869 citations indexed

About

Abhijit Pethe is a scholar working on Physiology, Electrical and Electronic Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Abhijit Pethe has authored 37 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 16 papers in Electrical and Electronic Engineering and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Abhijit Pethe's work include Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (12 papers) and Inhalation and Respiratory Drug Delivery (10 papers). Abhijit Pethe is often cited by papers focused on Asthma and respiratory diseases (17 papers), Respiratory and Cough-Related Research (12 papers) and Inhalation and Respiratory Drug Delivery (10 papers). Abhijit Pethe collaborates with scholars based in United States, Switzerland and South Africa. Abhijit Pethe's co-authors include Krishna C. Saraswat, Tejas Krishnamohan, Duygu Kuzum, Chi On Chui, Yasuhiro Oshima, Yun Sun, Paul C. McIntyre, Ali K. Okyay, P. Pianetta and Donghyun Kim and has published in prestigious journals such as Optics Letters, European Respiratory Journal and IEEE Transactions on Electron Devices.

In The Last Decade

Abhijit Pethe

32 papers receiving 842 citations

Peers

Countries citing papers authored by Abhijit Pethe

Since Specialization

Citations

This map shows the geographic impact of Abhijit Pethe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhijit Pethe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhijit Pethe more than expected).

Fields of papers citing papers by Abhijit Pethe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhijit Pethe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhijit Pethe. The network helps show where Abhijit Pethe may publish in the future.

Co-authorship network of co-authors of Abhijit Pethe

This figure shows the co-authorship network connecting the top 25 collaborators of Abhijit Pethe. A scholar is included among the top collaborators of Abhijit Pethe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abhijit Pethe. Abhijit Pethe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma 2023 ·Journal of Asthma and Allergy ·Richard N. van Zyl-Smit, Kenneth R. Chapman, Huib A.M. Kerstjens, Christian Geßner, Hironori Sagara, (unknown), (unknown), Abhijit Pethe, David Lawrence, Hanns-Christian Tillmann, Peter D’Andrea	0
2	True Random Number Generator Implemented in ReRAM Crossbar Based on Static Stochasticity of ReRAMs 2023 ·(unknown), Abhijit Pethe	0
3	Performance of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD: Evidence from Clinical and Online Patient Interaction Studies 2022 ·International Journal of COPD ·Francesco Patalano, (unknown), Abhijit Pethe, (unknown), Nancy Kline Leidy, Tasneem Arsiwala, (unknown), F Gutzwiller	3
4	Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies 2022 ·Journal of Asthma ·Hironori Sagara, Peter D’Andrea, (unknown), Abhijit Pethe, (unknown), (unknown), (unknown), Yoichi Nakamura	1
5	Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials 2021 ·Respiratory Medicine ·Emil Scosyrev, Richard N. van Zyl-Smit, Huib A.M. Kerstjens, Christian Geßner, Oliver Kornmann, Devendra Kumar Jain, (unknown), Peter D’Andrea, (unknown), Abhijit Pethe, Dominic E. A. Brittain	8
6	Ligelizumab treatment for severe asthma: learnings from the clinical development programme 2021 ·Clinical & Translational Immunology ·Jordis Trischler, (unknown), (unknown), Christoph Heusser, Xavier Jaumont, Philip J. Lowe, (unknown), Abhijit Pethe, Ralph Woessner, Hans‐Günter Zerwes, Stefan Zielen	31
7	Emergency Room Visits and Rescue Medication Use in Patients with Asthma in the IRIDIUM Study and Their Impact on Carbon Footprint 2021 ·K.M. Beeh, Richard N. van Zyl-Smit, Karen Mezzi, (unknown), Abhijit Pethe, Peter D’Andrea, Ashley Woodcock	1
8	Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians 2020 ·Asian Pacific Journal of Allergy and Immunology ·Jing Li, Jing Yang, Lingfei Kong, Yijiang Huang, Ping Chen, Xixin Yan, Xiaoxia Liu, (unknown), Jinming Liu, Xiaoli Zhu, Michael Humphries, Linda Wang, Abhijit Pethe, (unknown), Ioannis Kottakis, Robert Fogel, Nanshan Zhong	8
9	Medium-Dose Indacaterol/Glycopyrronium/Mometasone Furoate Fixed-Dose Combination Improves Lung Function Compared with High-Dose Indacaterol/Mometasone Furoate and Salmeterol/Fluticasone and Reduces Exacerbation Rates Versus High-Dose Salmeterol/Fluticasone in Moderate-to-Severe Asthma: The IRIDIUM Study 2020 ·Alberto Papi, Marc Humbert, Κonstantinos Κostikas, Christian Domingo, (unknown), (unknown), (unknown), Abhijit Pethe, (unknown), Peter D’Andrea	1
10	Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study 2020 ·The Lancet Respiratory Medicine ·Richard N. van Zyl-Smit, Matthias Krüll, Christian Geßner, Yasuhiro Gon, O. Noga, Alexia Richard, (unknown), Xu Shu, Abhijit Pethe, (unknown), Peter D’Andrea	33
11	Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study 2020 ·The Lancet Respiratory Medicine ·Huib A.M. Kerstjens, Jorge Máspero, Kenneth R. Chapman, Richard N. van Zyl-Smit, (unknown), (unknown), (unknown), Abhijit Pethe, Xu Shu, Peter D’Andrea	102
12	Fevipiprant, an oral prostaglandin DP₂receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids 2017 ·European Respiratory Journal ·Eric D. Bateman, (unknown), Florian Brockhaus, Björn Holzhauer, Abhijit Pethe, Richard Kay, Robert G. Townley	85
13	Tumor Cell Uptake of 99mTc-Labeled 1-Thio-β-d-Glucose and 5-Thio-d-Glucose in Comparison with 2-Deoxy-2-[18 F]Fluoro-d-Glucose In Vitro: Kinetics, Dependencies, Blockage and Cell Compartment of Accumulation 2013 ·Molecular Imaging and Biology ·Max Seidensticker, Gilles Ulrich, Fabian Muehlberg, Abhijit Pethe, Oliver S. Großer, Ingo G. Steffen, (unknown), Jürgen Goldschmidt, Karl‐Heinz Smalla, (unknown), Jens Ricke, Holger Amthauer, Konrad Mohnike	11
14	Ge Interface Passivation Techniques and Their Thermal Stability 2008 ·ECS Transactions ·Duygu Kuzum, Tejas Krishnamohan, Abhijit Pethe, Yasuhiro Oshima, Yun Sun, J.P. McVittie, Paul C. McIntyre, P. Pianetta, Krishna C. Saraswat	4
15	Germanium for High Performance MOSFETs and Optical Interconnects 2008 ·ECS Transactions ·Krishna C. Saraswat, Dong‐Hyun Kim, Tejas Krishnamohan, Duygu Kuzum, Ali K. Okyay, Abhijit Pethe, Hyun‐Yong Yu	14
16	Interface-Engineered Ge (100) and (111), N- and P-FETs with High Mobility 2007 ·Duygu Kuzum, Abhijit Pethe, Tejas Krishnamohan, Yasuhiro Oshima, Yun Sun, (unknown), P. Pianetta, Paul C. McIntyre, Krishna C. Saraswat	43
17	SiGe optoelectronic metal-oxide semiconductor field-effect transistor 2007 ·Optics Letters ·Ali K. Okyay, Abhijit Pethe, Duygu Kuzum, Salman Latif, David A. B. Miller, Krishna C. Saraswat	18
18	High performance germanium MOSFETs 2006 ·Materials Science and Engineering B ·Krishna C. Saraswat, Chi On Chui, Tejas Krishnamohan, Donghyun Kim, Ammar Nayfeh, Abhijit Pethe	120
19	Investigation of the Performance Limits of III-V Double-Gate n-MOSFETs 2006 ·Abhijit Pethe, Tejas Krishnamohan, DongHyun Kim, Saeroonter Oh, H.‐S. Philip Wong, Krishna C. Saraswat	16
20	High Mobility Materials and Novel Device Structures for High Performance Nanoscale MOSFETs 2006 ·Krishna C. Saraswat, Chi On Chui, Donghyun Kim, Tejas Krishnamohan, Abhijit Pethe	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact